{"DataElement":{"publicId":"6586590","version":"1","preferredName":"Choroid and Ciliary Body Uveal Melanoma AJCC Edition 8 Pathologic Distant Metastasis M Category","preferredDefinition":"Extent of the distant metastasis for choroidal and ciliary body melanoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.","longName":"CCB_AJC8_PTH_M_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6586425","version":"1","preferredName":"Choroid And Ciliary Body Uveal Melanoma Pathologic M Category","preferredDefinition":"A blood vessel-containing membrane of the eye that lies between the retina and the sclera._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._Tissue located behind the iris and composed of muscle and epithelium. Its functions include the production of aqueous humor and changing the shape of the crystalline lens._A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. M refers to the presence of metastasis.","longName":"6586235v1.0:2207807v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6586235","version":"1","preferredName":"Choroid And Ciliary Body Uveal Melanoma","preferredDefinition":"A blood vessel-containing membrane of the eye that lies between the retina and the sclera.:An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.:Tissue located behind the iris and composed of muscle and epithelium. Its functions include the production of aqueous humor and changing the shape of the crystalline lens.:A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","longName":"C12344:C37912:C12345:C7712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choroid","conceptCode":"C12344","definition":"A blood vessel-containing membrane of the eye that lies between the retina and the sclera.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ciliary Body","conceptCode":"C12345","definition":"Tissue located behind the iris and composed of muscle and epithelium. Its functions include the production of aqueous humor and changing the shape of the crystalline lens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Uveal Melanoma","conceptCode":"C7712","definition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB15681-4CE4-0958-E053-F662850A2AAD","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207807","version":"1","preferredName":"Pathologic M Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25610:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30F5-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7CB14677-C706-0968-E053-F662850A4A2E","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"TAYLORT","dateModified":"2019-09-06","changeDescription":"9-6-19 TMT released per MC.; 12/10/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6586505","version":"1","preferredName":"Uveal Melanoma American Joint Committee on Cancer Edition 8 Pathologic M Category","preferredDefinition":"A pathologic finding about one or more characteristics of uveal melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.","longName":"6586505v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pM1c","valueDescription":"Uveal Melanoma pM1c TNM Finding v8","ValueMeaning":{"publicId":"6586507","version":"1","preferredName":"Uveal Melanoma pM1c TNM Finding v8","longName":"6586507","preferredDefinition":"Uveal melanoma with largest diameter of the largest metastasis 8.1 cm or more. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma pM1c TNM Finding v8","conceptCode":"C140616","definition":"Uveal melanoma with largest diameter of the largest metastasis 8.1 cm or more. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBF2AB0-2425-105A-E053-F662850A39C6","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBF2AB0-243E-105A-E053-F662850A39C6","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"},{"value":"pM1b","valueDescription":"Uveal Melanoma pM1b TNM Finding v8","ValueMeaning":{"publicId":"6586509","version":"1","preferredName":"Uveal Melanoma pM1b TNM Finding v8","longName":"6586509","preferredDefinition":"Uveal melanoma with largest diameter of the largest metastasis 3.1-8.0 cm. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma pM1b TNM Finding v8","conceptCode":"C140615","definition":"Uveal melanoma with largest diameter of the largest metastasis 3.1-8.0 cm. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBF2AB0-244B-105A-E053-F662850A39C6","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBF2AB0-2464-105A-E053-F662850A39C6","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"},{"value":"pM1a","valueDescription":"Uveal Melanoma pM1a TNM Finding v8","ValueMeaning":{"publicId":"6586511","version":"1","preferredName":"Uveal Melanoma pM1a TNM Finding v8","longName":"6586511","preferredDefinition":"Uveal melanoma with largest diameter of the largest metastasis 3.0 cm or less. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma pM1a TNM Finding v8","conceptCode":"C140614","definition":"Uveal melanoma with largest diameter of the largest metastasis 3.0 cm or less. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBF2AB0-2471-105A-E053-F662850A39C6","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBF2AB0-248A-105A-E053-F662850A39C6","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"},{"value":"cM0","valueDescription":"Uveal Melanoma cM0 TNM Finding v8","ValueMeaning":{"publicId":"6586499","version":"1","preferredName":"Uveal Melanoma cM0 TNM Finding v8","longName":"6586499","preferredDefinition":"Uveal melanoma with no distant metastasis by clinical classification. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma cM0 TNM Finding v8","conceptCode":"C140606","definition":"Uveal melanoma with no distant metastasis by clinical classification. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB2C579-95D6-05B0-E053-F662850A757D","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBF2AB0-2494-105A-E053-F662850A39C6","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"},{"value":"cM1","valueDescription":"Uveal Melanoma cM1 TNM Finding v8","ValueMeaning":{"publicId":"6586497","version":"1","preferredName":"Uveal Melanoma cM1 TNM Finding v8","longName":"6586497","preferredDefinition":"Uveal melanoma with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma cM1 TNM Finding v8","conceptCode":"C140607","definition":"Uveal melanoma with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB2C579-95B0-05B0-E053-F662850A757D","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBF2AB0-249E-105A-E053-F662850A39C6","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"},{"value":"pM1","valueDescription":"Uveal Melanoma pM1 TNM Finding v8","ValueMeaning":{"publicId":"6586489","version":"1","preferredName":"Uveal Melanoma pM1 TNM Finding v8","longName":"6586489","preferredDefinition":"Uveal melanoma with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma pM1 TNM Finding v8","conceptCode":"C140613","definition":"Uveal melanoma with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CB2C579-9518-05B0-E053-F662850A757D","latestVersionIndicator":"Yes","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-10","modifiedBy":"ONEDATA","dateModified":"2018-12-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7CBF2AB0-24A8-105A-E053-F662850A39C6","beginDate":"2018-12-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6586504","version":"1","preferredName":"Uveal Melanoma Pathologic Distant Metastasis TNM Finding v8 American Joint Committee on Cancer M Category Category","preferredDefinition":"A pathologic finding about one or more characteristics of uveal melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. M refers to the presence of metastasis.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C140612:C39315:C25727:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveal Melanoma Pathologic Distant Metastasis TNM Finding v8","conceptCode":"C140612","definition":"A pathologic finding about one or more characteristics of uveal melanoma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CBF2AB0-23F8-105A-E053-F662850A39C6","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"ONEDATA","dateModified":"2018-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7CBF2AB0-2409-105A-E053-F662850A39C6","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"TAYLORT","dateModified":"2019-09-06","changeDescription":"9-6-19 TMT released per MC.; 12/11/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6581919","version":"1","longName":"Uveal","context":"NCI Standards"}]},{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776735","version":"1","longName":"Eye","context":"OCCPR"},{"publicId":"6779574","version":"1","longName":"UVM Baseline","context":"OCCPR"}]}],"AlternateNames":[{"name":"OCCPR","type":"USED_BY","context":"OCCPR"}],"ReferenceDocuments":[{"name":"Pathologic M category","type":"Preferred Question Text","description":"Pathologic M category","url":null,"context":"NCI Standards"},{"name":"CPTAC-BSLN-1","type":"Alternate Question Text","description":"Pathologic Distant Metastasis Status (pM)","url":null,"context":"OCCPR"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7CC000B0-CDC9-7667-E053-F662850AA685","latestVersionIndicator":"Yes","beginDate":"2018-12-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-12-11","modifiedBy":"KNABLEJ","dateModified":"2020-05-13","changeDescription":"9-6-19 TMT released per MC.; 12/11/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}